---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-029646"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:50:14.127877+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Prime Medicine shareholders elect Cahill and Nelsen as Class III directors, ratify PwC

## Summary
- Thomas Cahill elected with 74,446,103 For, 8,336,569 Withheld, 15,311,067 broker non-votes.
- Robert Nelsen elected with 70,607,668 For, 12,175,004 Withheld, 15,311,067 broker non-votes.
- Ratification of PricewaterhouseCoopers as auditor passed: 98,008,974 For, 42,555 Against, 42,210 Abstentions.
- Quorum of 98,093,739 shares present (74.8% of 131,160,842 outstanding shares).

## SEC filing metadata
- accession: 0001628280-25-029646
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000162828025029646/0001628280-25-029646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000162828025029646/prme-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-029646
- JSON: https://secwatch.observer/filing/0001628280-25-029646.json
- Plain text: https://secwatch.observer/filing/0001628280-25-029646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.